Home/Filings/4/0001013762-21-000025
4//SEC Filing

TAMER ANTHONY 4

Accession 0001013762-21-000025

CIK 0001817944other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:09 PM ET

Size

18.7 KB

Accession

0001013762-21-000025

Insider Transaction Report

Form 4
Period: 2021-09-09
Transactions
  • Award

    Common Stock

    2021-09-09+2,470,7562,470,756 total(indirect: See Footnote)
  • Award

    Common Stock

    2021-09-09+490,531490,531 total(indirect: See Footnote)
  • Award

    Common Stock

    2021-09-09+2,731,0942,731,094 total(indirect: See Footnote)
Footnotes (4)
  • [F1]Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the "Issuer"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. ("Legacy Clarus") (the "Merger Agreement") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer.
  • [F2]The shares reported are held of record by H.I.G. Bio -- Clarus I, L.P ("Clarus I"). H.I.G.-GPII, Inc. ("H.I.G. GP") is the general partner of Clarus I and has sole voting and investment control over the shares owned by Clarus I. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by Clarus I. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any.
  • [F3]The shares reported are held of record by H.I.G. Ventures - Clarus, LLC ("H.I.G. Ventures"). H.I.G. GP is the manager of H.I.G. Ventures and has sole voting and investment control over the shares owned by H.I.G. Ventures. Mr. Tamer and Mr. Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Ventures. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any.
  • [F4]The shares reported are held of record by H.I.G. Bio -- Clarus II, L.P ("Clarus II"). H.I.G. GP is the general partner of Clarus II and has sole voting and investment control over the shares owned by Clarus II. Mr. Tamer and Mr. Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by Clarus II. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any.

Documents

1 file

Issuer

Clarus Therapeutics Holdings, Inc.

CIK 0001817944

Entity typeother

Related Parties

1
  • filerCIK 0001050045

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:09 PM ET
Size
18.7 KB